Aclaris Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,777 | $1,455 | $9,211 | $4,346 |
Gross Profit | 1,262 | 949 | -90 | 1,938 |
EBITDA | -15,215 | -17,656 | -13,927 | -9,492 |
EBIT | -15,429 | -17,784 | -14,070 | -9,671 |
Net Income | -15,429 | -15,085 | -96,552 | -7,586 |
Net Change In Cash | 1,777 | 1,455 | 9,211 | 4,346 |
Free Cash Flow | -10,014 | -13,100 | -44,748 | 22,000 |
Cash | 25,402 | 30,357 | 24,570 | 47,651 |
Basic Shares | 122,580 | 122,390 | 95,305 | 71,381 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $18,720 | $31,249 | $29,752 | $6,761 |
Gross Profit | 15,928 | 13,168 | 17,792 | 2,048 |
EBITDA | -51,720 | -87,985 | -84,357 | -64,461 |
EBIT | -52,527 | -88,848 | -85,154 | -65,384 |
Net Income | -132,065 | -88,481 | -86,908 | -90,865 |
Net Change In Cash | 18,720 | 31,249 | 29,752 | 6,761 |
Cost of Revenue | 17,928 | 5,286 | ||
Free Cash Flow | -20,196 | -79,634 | -68,172 | -52,442 |
Cash | 24,570 | 39,878 | 45,277 | 27,349 |
Basic Shares | 77,296 | 69,808 | 65,213 | 56,730 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.13 |
2025-03-31 | -$0.12 |
2024-12-31 | -$1.01 |
